Evonik acquires surface modification business from Interface Biologics
08:40 AM | September 4, 2019 | Natasha Alperowicz
Deal will help expand Evonik's health and care operation.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.